跳至主要内容
临床试验/CTRI/2024/12/077775
CTRI/2024/12/077775招募中3 期

Efficacy of Indian make Transcutaneous Electric Nerve Stimulation Device Matri in women with Primary Dysmenorrhoea- A Randomized Controlled Trial

Biotechnology ignition grant BIG1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2024年12月16日最近更新:

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
120
试验地点
1
主要终点
1. To evaluate the effectiveness of the new Indian make TENS device (Matri)

研究概览

简要总结

Primary dysmenorrhea is a common gynaecological problem consisting of painful

cramps accompanying menstruation, without any evident pathology to account to it.

The uterus is induced to contract frequently and disrhythmically, with increased basal

tone and increased active pressure. The disease occurs in up to 50% of menstruating

females and causes significant disruption in quality of life in 20%, resulting in non-

attendance at work or school (1-4). The available treatment for this are nonsteroidal

anti-inflammatory drugs and oral contraceptive pills OCPs which are often associated

with adverse events (AEs). So many patients avoid taking them, and seek for other

non-pharmaceutical alternatives.

Transcutaneous electrical nerve stimulation (TENS), working on Gate control theory,

is an established method for pain relief in various chronic conditions such as arthritis,

back pain etc. This method offers a potential non-pharmaceutical alternative therapy

for dysmenorrhea. It has been used in few research projects but is still not widely used

for this indication (5-8).

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Participant and Outcome Assessor Blinded

入排标准

年龄范围
14.00 Year(s) 至 30.00 Year(s)(—)
性别
Female

入选标准

  • Women suffering from primary dysmenorrhoea with regular cycles
  • Working ability, Location, Intensity, Days of dysmenorrhea score (WaLIDD score) more than or equal 5

排除标准

  • Women taking Oral Contraceptive Pills OCPs
  • Patients with dysmenorrhea secondary to the pathologies like endometriosis, uterine myoma, uterine malformations, other similar uterine diseases, pelvic inflammatory disease, congenital Mullerian anomalies, ovarian cysts, or inflammatory bowel disease.

结局指标

主要结局

1. To evaluate the effectiveness of the new Indian make TENS device (Matri)

时间窗: 1. To evaluate the effectiveness of the new Indian make TENS device (Matri) | for managing Primary Dysmenorrhoea using subjective Visual Analog Scale | pain score (VAS score) at base line , 1 month and 2nd month from base line

for managing Primary Dysmenorrhoea using subjective Visual Analog Scale

时间窗: 1. To evaluate the effectiveness of the new Indian make TENS device (Matri) | for managing Primary Dysmenorrhoea using subjective Visual Analog Scale | pain score (VAS score) at base line , 1 month and 2nd month from base line

pain score (VAS score)

时间窗: 1. To evaluate the effectiveness of the new Indian make TENS device (Matri) | for managing Primary Dysmenorrhoea using subjective Visual Analog Scale | pain score (VAS score) at base line , 1 month and 2nd month from base line

次要结局

  • 1. To assess the perceived adverse reactions of the new Indian make(Transcutaneous Electric Nerve Stimulation TENS Device (Matri))

研究者

发起方
Biotechnology ignition grant BIG
申办方类型
Government funding agency
责任方
Principal Investigator
主要研究者

Dr Ritu Sharma

Government Institute of Medical Sciences (GIMS)

研究点 (1)

Loading locations...

相似试验